Quick Links
Share with Colleagues Credits
Physicians: .25 AMA PRA Category I CreditsTM To Receive Credit In order to receive your certificate of participation, you should read the information about this activity, including the disclosure statements, review the entire activity, take the post-test, and complete the evaluation form. You may then follow the directions to print your certificate of participation. To begin, click the CME icon above. Program Overview Learning Objectives
Upon successful completion of this educational program, the reader should be able to: Faculty Information
Alan Ehrlich, MD Disclosures
Dr. Ehrlich, Dr. Fleming, DynaMed Editorial Team members, and the staff of Antidote Education Company have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity. Accreditation Statements ACCME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Antidote Education Company and EBSCO Publishing. Antidote is accredited by the ACCME to provide continuing medical education for physicians. Antidote Education Company designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. DynaMed Careers
Looking for a change? The DynaMed editorial team is expanding and looking for talented and driven individuals. Visit the links below to learn about these exciting opportunities. DynaMed Contribution Opportunities
DynaMed Peer Review |
Last week 383 journal articles were evaluated via DynaMed's Systematic Literature Surveillance and summaries of 237 articles were added to DynaMed content. |
CAM-S Severity Score May Help Predict 90-Day Mortality and Length of Hospital Stay in Hospitalized Patients ≥ 70 Years Old Without Delirium |
|
Hospitalized patients are at an increased risk of delirium, with incidence rates ranging from 3%-29% for new-onset delirium during hospitalization (Age Ageing 2006 Jul;35(4):350 full-text). The Confusion Assessment Method (CAM) is a validated assessment tool that has been shown to reliably identify delirium in several different patient populations (J Am Geriatr Soc 2008 May;56(5):823 full-text), and may be used in screening for delirium on hospital admission. A recent prospective cohort study evaluated a new CAM-Severity (CAM-S) score to predict adverse outcomes in hospitalized patients ≥ 70 years old without delirium on admission.
The CAM-S score was used to categorize patients into 4 different risk groups: none (0 points), low (1 point), moderate (2 points), and high (3-7 points). In the validation cohort, 90-day mortality was 7% among 598 patients with no risk factors, 15% among 91 patients in the low risk category, 16% among 128 patients in the moderate risk category, and 27% among 102 in the high risk category (p for trend < 0.001). Similarly, adjusted mean length of hospital stay was 6.5 days with no risk factors, 8.8 days for the low risk category, 11.1 days for the moderate risk category, and 12.7 days for the high risk category (p for trend < 0.001). Increased CAM-S short form scores were also associated with increased risk of new nursing home placement, functional decline, and cognitive decline (p for trend < 0.001 for each). The prediction of adverse patient outcomes with the CAM-S short form was also consistent with a 10-item long form of CAM-S (total score 0-19 points). |
|
News About Mobile Access
On April 16, 2014, Physicians Interactive launched Omnio® 3 for iPhone/iPad/iPod touch as a free update for the existing Skyscape Medical Resources (SMR) app. The Android version will be available by the end of the month. DynaMed is compatible with Omnio 3 on both platforms. |
|
DynaMed Events American Society of Clinical Oncology (ASCO) 50th Annual MeetingMay 30-June 3, 2014 DynaMed Founder and Vice President Brian Alper, MD, will be attending the American Society of Clinical Oncology(ASCO) 50th Annual Meeting, held at McCormack Place in Chicago, Illinois. Representatives will be available to discuss peer review, mobile access, and free trial information. Senior Deputy Editor Alan Ehrlich, MD, will be attending the Massachusetts Medical Society (MMS) CME Event and Conference on Medical Marijuana: Regs, Responsibilities & Communication, held at the MMS Headquarters at Waltham Woods in Waltham, Massachusetts. Representatives will be available to discuss peer review, mobile access, and free trial information. |
|
PEMSoft Mobile is Now Live Access the definitive resource for pediatric clinical information right from your Apple or Android device.
For more information and technical support, visit the PEMSoft Mobile Access page |
|
Call for Peer Reviews
We are currently seeking subspecialty reviewers for our Patient Education Resource Center (PERC). PERC provides fact sheets and discharge instructions for patients leaving the hospital or emergency room. These hand-outs fulfill the meaningful use requirements for the Medicare & Medicare Services Incentive Programs. |